Japan's Takeda has entered into a new manufacturing partnership with Hyderabad-based Biological E. Limited (BE) in India to boost production capacity for its dengue fever vaccine Qdenga. This collaboration aims to accelerate access to Qdenga and brings Takeda closer to its goal of producing 100 million doses of the vaccine...
India’s Biotech Startup Eyestem Raises $6.4 Mn
Headquartered in Bangalore and Delaware, cell therapy startup Eyestem secured $6.4 million in its Series A funding round at a post-money valuation of $46.4 million. The funding was led by three Indian pharma majors- Biological E. Limited, Alkem, NATCO and Anurag and Karan Bagaria, promoters of Kemwell Biopharma. Existing investors...